Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,975,358
+$122,122 QoQ
Shares Held
21,229
+1.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#108
of 282 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. BNTX ranks #39 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
578,634 | $287,424,866 | |
| 2 | ARGX |
Argenx SE
|
301,000 | $279,258,770 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,048,014 | $196,272,061 | |
| 4 | ORKA |
Oruka Therapeutics, Inc.
|
1,657,190 | $157,714,772 | |
| 5 | INSM |
INSMED Inc
|
1,393,418 | $148,566,226 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,449,547 | $134,725,085 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,731,909 | $123,665,167 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
6,185,970 | $115,739,498 |
All Filings in BNTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,975,358 | 21,229 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,853,236 | 20,851 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,165,475 | 43,755 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,348,641 | 33,955 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,730,601 | 35,039 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $725,201 | 7,964 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $949,431 | 8,332 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,035,793 | 8,721 | Shares | Defined | 2024-11-14 | |
| 2023-03-31 | $24,475,513 | 196,480 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $33,210,637 | 221,080 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $20,714,870 | 153,580 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,543,920 | 151,200 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $19,062,808 | 111,766 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $29,251,534 | 113,466 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $3,466,973 | 12,700 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,059,688 | 22,600 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $4,968,145 | 45,500 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,467,360 | 18,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,426,885 | 49,500 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,337,000 | 50,000 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||